, Switzerland introduced out-of-pocket price differentiation. As of July 1st 2011, substitutable pharmaceuticals with prices above a … from public sources and patient drug use data from two Swiss health insurers, we analyze the price and demand response of … from generic producers than from firms producing brand-name drugs. Regarding demand, we exploit a natural experiment in …

The extent of pharmaceutical advertising and promotion can be characterized by a balancing act between profitable … demand expansions and potentially unfavorable subsequent regulatory actions. However, this balance also depends on the nature … scenarios and test the model's predictions using a novel combination of sales, promotion, advertising, and adverse event reports …